Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTL0018318 in Dementia With Lewy Bodies
NCT03592862Phase 2Withdrawn
- Sponsor
- Nxera Pharma
- Start
- Jul 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HTL0018318 in dementia with Lewy bodies (DLB), sponsored by Nxera Pharma. Planned start Jul 2019; status: withdrawn.
02
Drugs
HTL0018318
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on NCT03592862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03592862.